Hansa Biopharma participating in Wedbush PacGrow Renal Summit

Rhea-AI Summary

Hansa Biopharma (Nasdaq Stockholm: HNSA) announced that COO and President U.S. Maria Törnsén will join a fireside chat titled “Don’t Be So Sensitive - Bringing Kidneys to the Over-Sensitized” with Dr. Leonardo Riella at the Wedbush PacGrow Renal Summit in Boston on July 8, 2026, 1:10–1:50 PM EDT.

Market Context

Hansa Biopharma’s planned fireside chat at the Wedbush PacGrow Renal Summit on July 8, 2026 increase...

Analysis

Hansa Biopharma’s planned fireside chat at the Wedbush PacGrow Renal Summit on July 8, 2026 increases investor-facing visibility but adds no new financial, clinical, or regulatory data, leaving future updates as the key catalysts to monitor.

Key Figures

Event date: July 8, 2026 Start time: 1:10 PM EDT End time: 1:50 PM EDT

3 metrics

Event date July 8, 2026 Wedbush PacGrow Renal Summit

Start time 1:10 PM EDT Fireside chat start

End time 1:50 PM EDT Fireside chat end

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LUND, Sweden, July 2, 2026 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that Maria Törnsén, COO and President U.S., Hansa Biopharma, will participate in a fireside chat titled "Don't Be So Sensitive - Bringing Kidneys to the Over-Sensitized" with Dr. Leonardo Riella, Massachusetts General Hospital, at the Wedbush PacGrow Renal Summit in Boston, at 1:10 PM EDT on Wednesday, July 8, 2026.

If you are interested in meeting with Hansa's management, please contact Hansa Biopharma at ir@hansabiopharma.com.

Event: Fireside chat at Wedbush PacGrow Renal Summit

Title: "Don't Be So Sensitive - Bringing Kidneys to the Over-Sensitized"

Date, Time, and Place: Wednesday July 8, 1:10-1:50 PM EDT, at the Newbury Hotel in Boston

Speakers: Maria Törnsén, COO and President U.S., Hansa Biopharma, and Dr. Leonardo Riella, Massachusetts General Hospital

Contacts for more information:

Kerstin Falck, VP Global Corporate Affairs
media@hansabiopharma.com
IR@hansabiopharma.com

Notes to editors

About Hansa Biopharma

Hansa Biopharma AB is a pioneering commercial-stage biopharmaceutical company developing and commercializing novel immunomodulatory therapies to transform care for patients with acute or complex immune disorders. Hansa's proprietary IgG-cleaving enzyme technology platform addresses serious unmet medical needs in transplantation, gene therapy and autoimmune diseases. The company's portfolio includes imlifidase, a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme therapy, which has been shown to enable kidney transplantation in highly sensitized patients, and HNSA-5487, a next-generation IgG-cleaving molecule that will be developed for Guillain-Barré Syndrome (GBS). Hansa Biopharma is based in Lund, Sweden, and has operations in Europe and the U.S. The company is listed on Nasdaq Stockholm under the ticker HNSA. Find out more at www.hansabiopharma.com and follow us on LinkedIn.

©2026 Hansa Biopharma AB. Hansa Biopharma, the beacon logo, IDEFIRIX, and IDEFIRIX flower logo are trademarks of Hansa Biopharma AB, Lund, Sweden. All rights reserved.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-participating-in-wedbush-pacgrow-renal-summit,c4370382

The following files are available for download:

https://mb.cision.com/Main/1219/4370382/4178391.pdf

2026-07 Wedbush Renal Summit ENG

View original content:https://www.prnewswire.com/news-releases/hansa-biopharma-participating-in-wedbush-pacgrow-renal-summit-302816848.html

SOURCE Hansa Biopharma AB

FAQ

What is Hansa Biopharma (HNSA) doing at the Wedbush PacGrow Renal Summit on July 8, 2026?

Hansa Biopharma will participate in a fireside chat at the Wedbush PacGrow Renal Summit. According to Hansa Biopharma, COO and President U.S. Maria Törnsén will speak alongside Dr. Leonardo Riella about treating over-sensitized kidney patients.

When and where is Hansa Biopharma’s HNSA fireside chat at the Wedbush PacGrow Renal Summit?

The fireside chat is scheduled for July 8, 2026, from 1:10 to 1:50 PM EDT. According to Hansa Biopharma, it will take place at the Newbury Hotel in Boston during the Wedbush PacGrow Renal Summit.

Who will represent Hansa Biopharma (HNSA) at the Wedbush PacGrow Renal Summit fireside chat?

Hansa Biopharma will be represented by Maria Törnsén, COO and President U.S. According to Hansa Biopharma, she will speak together with Dr. Leonardo Riella from Massachusetts General Hospital on over-sensitized kidney patients.

How can investors arrange a meeting with Hansa Biopharma management during the Wedbush PacGrow Renal Summit?

Investors can request meetings by emailing Hansa Biopharma’s investor relations team. According to Hansa Biopharma, interested parties should contact the company at ir@hansabiopharma.com to explore scheduling with management around the Wedbush PacGrow Renal Summit.

What is the topic of Hansa Biopharma’s HNSA session "Don’t Be So Sensitive - Bringing Kidneys to the Over-Sensitized"?

The session focuses on bringing kidneys to over-sensitized patients, as reflected in its title. According to Hansa Biopharma, the fireside chat pairs Maria Törnsén with nephrologist Dr. Leonardo Riella at the Wedbush PacGrow Renal Summit.